FDA Approved: BAFIERTAM — Supplemental Application (Banner Life Sciences LLC)

View source ↗

Summary

The FDA approved a supplemental application for BAFIERTAM (monomethyl fumarate) submitted by Banner Life Sciences LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• BAFIERTAM (MONOMETHYL FUMARATE)

Snippet

SUPPL AP for BAFIERTAM (MONOMETHYL FUMARATE)